Journal Name: Lancet Microbe
Journal Type: Q1
ISSN: 26665247
Country: United Kingdom
Subject Area and Category: Immunology and Microbiology Microbiology Virology Medicine Infectious Diseases Microbiology (medical)
Publisher: Elsevier Ltd
Research Ranking: 296
Publication Type: Journals
H-Index: 53
Coverage: 2020-2025
Editors-in-Chief: Onisillos Sekkides
Research Impact Score: 9.6
Impact Factor: 20.9
SCIMAGO SJR: 5.262
APC Cost: USD 7,280,
Submission Link: https://www.thelancet.com/journals/lanmic/home
Contact Email: microbe@lancet.com
Address: London, New York City and Beijing
Overview
The Lancet Microbe is a prominent open-access journal that focuses on all aspects of microbial science with direct implications for human health. Launched as part of the prestigious Lancet family of journals, The Lancet Microbe serves as a vital platform for cutting-edge research in microbiology, infectious diseases, antimicrobial resistance, and pathogen-host interactions. The journal's rigorous peer-review standards and global reach make it a trusted source for academics, clinicians, and public health professionals worldwide.
Scope and Focus Areas
The Lancet Microbe publishes high-impact original research, reviews, commentaries, and opinion pieces that span a wide array of microbiological disciplines. The journal welcomes studies on pathogenic bacteria, viruses, fungi, and parasites, as well as investigations into microbial communities and their effects on health and disease. Key focus areas include:
-
Mechanisms of antimicrobial resistance (AMR)
-
Diagnostic microbiology and novel technologies
-
Epidemiology and surveillance of emerging pathogens
-
Microbiome research and its clinical relevance
-
Vaccine development and therapeutic innovations
-
Host-pathogen interactions at the molecular level
The journal is also committed to publishing research that supports global public health goals, particularly in low- and middle-income countries, where infectious diseases remain a major burden.
Why The Lancet Microbe Stands Out
What sets The Lancet Microbe apart is its dedication to scientific rigor and societal impact. Every article undergoes a thorough editorial and peer-review process to ensure it meets the journal's high standards for accuracy, transparency, and relevance. In addition, the journal maintains a strong commitment to open-access publishing, making its content freely available to researchers and practitioners around the world.
The journal’s editorial team prioritizes diversity in research, welcoming submissions from underrepresented regions and encouraging interdisciplinary approaches that connect microbiology with epidemiology, immunology, pharmacology, and environmental science.
Impact on Global Health
By focusing on real-world challenges such as the rise of antimicrobial resistance, pandemic preparedness, and the development of rapid diagnostics, The Lancet Microbe plays a critical role in shaping policy and clinical practice. The journal contributes to the global dialogue on infectious disease control, biosecurity, and sustainable health interventions.
About
The Lancet Microbe is a peer-reviewed, open-access medical journal that focuses exclusively on microbiology and its implications for global health. As part of the renowned Lancet family, The Lancet Microbe delivers high-quality research articles, reviews, and commentaries that address urgent issues in microbial science, including infectious diseases, antimicrobial resistance, diagnostics, and pathogen-host interactions.
Launched in 2020, The Lancet Microbe quickly established itself as a critical platform for microbiologists, epidemiologists, clinicians, and public health professionals. With its strong emphasis on scientific rigor, global relevance, and open-access publishing, the journal aims to support evidence-based decision-making in health systems worldwide.
What Does The Lancet Microbe Cover?
The Lancet Microbe publishes original research and expert analysis across a wide range of microbiology-related topics. These include:
-
Antimicrobial resistance (AMR): The journal features pioneering studies on resistance mechanisms, global surveillance data, and strategies to combat AMR, a growing threat to public health.
-
Emerging infectious diseases: Research on newly discovered pathogens, pandemic preparedness, and viral evolution is regularly featured.
-
Microbiome science: Articles explore the human microbiome’s role in health, disease prevention, and potential therapies.
-
Diagnostic innovations: The journal showcases advances in diagnostic tools and laboratory methods for detecting infectious diseases.
-
Vaccines and therapeutics: Groundbreaking research on vaccine development, drug discovery, and treatment options is a core focus.
A Global Perspective on Microbial Science
What distinguishes The Lancet Microbe from other microbiology journals is its global approach to research. The journal actively encourages submissions from low- and middle-income countries and prioritizes studies that address health disparities and region-specific microbial threats. It plays a vital role in shaping health policy through scientifically grounded content accessible to international audiences.
Open Access and Editorial Excellence
As an open-access medical journal, The Lancet Microbe ensures that all its published research is freely available to readers worldwide. This open-access model promotes equity in science, allowing researchers, healthcare providers, and policymakers unrestricted access to cutting-edge data and expert perspectives.
The journal maintains a rigorous peer-review process and upholds the highest standards of scientific publishing. With a diverse editorial board composed of leading experts in microbiology, infectious disease, immunology, and global health, the journal guarantees authoritative and timely content.
Why The Lancet Microbe Matters
In an age where microbial threats can spark global crises, The Lancet Microbe serves as a trusted resource for the scientific and medical communities. It supports innovation, drives collaboration, and amplifies research that can save lives and protect public health on a global scale.
Whether you are a microbiologist, infectious disease researcher, or public health leader, The Lancet Microbe offers the insights and evidence you need to stay at the forefront of microbial science.
Scope
The Lancet Microbe is a leading open-access journal dedicated to publishing high-impact research in microbiology with a clear focus on human health. As a member of the esteemed Lancet journal family, The Lancet Microbe fills a vital niche by providing a global platform for innovative studies on pathogens, microbial communities, and host-microbe interactions. The journal’s broad and interdisciplinary scope allows it to serve as a critical resource for microbiologists, infectious disease specialists, epidemiologists, and public health professionals.
Comprehensive Scope of The Lancet Microbe
The scope of The Lancet Microbe covers the full spectrum of microbiological research that is relevant to human health. The journal welcomes submissions on a variety of topics, including but not limited to:
1. Antimicrobial Resistance (AMR)
One of the journal’s core areas of focus is antimicrobial resistance, a growing global health crisis. The Lancet Microbe publishes original research on the mechanisms of AMR, surveillance studies, resistance gene mapping, and strategies for mitigation. The journal also explores the policy implications of AMR and promotes cross-disciplinary collaboration to address this urgent threat.
2. Infectious Disease Pathogenesis
The journal features research on the biology of pathogens—bacteria, viruses, fungi, and parasites—and their role in causing human disease. Studies on pathogen evolution, transmission dynamics, and virulence factors are central to its scope.
3. Host–Microbe Interactions
Understanding how microbes interact with human hosts is key to combating infectious diseases. The Lancet Microbe encourages submissions that explore molecular and cellular mechanisms of host response, immune evasion, and inflammation, as well as the microbiome’s influence on health and disease.
4. Diagnostics and Surveillance
The journal supports innovation in microbial diagnostics, including molecular testing, rapid detection technologies, and laboratory tools that improve disease surveillance. These advances are crucial for early outbreak detection, clinical decision-making, and public health interventions.
5. Microbiome and Health
The role of the human microbiome in modulating immune responses, influencing metabolism, and preventing disease is a growing area of interest. The Lancet Microbe provides a platform for microbiome studies with clinical and therapeutic relevance.
6. Vaccines and Therapeutics
Research on the development, effectiveness, and deployment of vaccines and antimicrobial treatments falls within the journal’s scope. This includes studies on novel drug targets, resistance mechanisms, and clinical trials related to infectious diseases.
Global and Inclusive Research
The Lancet Microbe prioritizes research with global significance, especially studies from low- and middle-income countries (LMICs) where the burden of infectious disease is often highest. The journal encourages submissions that highlight regional challenges, local surveillance efforts, and equitable solutions to global microbiological threats.